Table 4.
Transplant Ineligibility Factors
| Factor | Rationale |
|---|---|
| Obstructive coronary artery disease not amenable to revascularization | Patients with medically-managed obstructive coronary artery disease without revascularization have nearly 100% intra-operative and post-operative morbidity and mortality.[82] |
| Systolic heart failure | Profound hemodynamic changes during LT require adequate compensatory cardiac function.[83] |
| Pulmonary hypertension (mPAP ≥ 35 mmHg) not correctable with medical therapy | Perioperative mortality associated with mPAP ≥ 50 mmHg is 100%; mortality for mPAP 35–50 mmHg is 50%.[84] |
| Severe intrinsic pulmonary disease | Impaired pulmonary function is associated with increased post-transplant length of stay and ventilator time.[85] |
| Class 3 obesity (BMI ≥ 40 kg/m2) | Obesity is associated with increased transplant operative time, wound infections and dehiscence, overall infections, postoperative respiratory failure, and hospital length of stay.[86] |
| Inability to maintain abstinence from alcohol or illicit substances | A short duration of abstinence before transplant is associated with post-transplant recidivism, which results in decreased survival.[87,88] |
| Persistent nonadherence to medical recommendations | Pre-transplant nonadherence predicts post-transplant nonadherence, which results in organ rejection and graft loss.[89,90] |
| Lack of adequate social support | Social support is necessary to aid the transplant recipient in maintaining their health through assisting with appointments, necessary testing, and medications. |
| Hepatocellular carcinoma with extrahepatic spread | Patients with advanced HCC have a limited life expectancy that cannot be corrected with LT. |
| Intrahepatic cholangiocarcinoma | Following LT with intrahepatic cholangiocarcinoma, recurrence was found in 57%, and 5-year survival was 51%.[91] |
| Active extrahepatic malignancy | Post-transplant cancer recurrence rates are associated with the duration of remission and vary based on the type of cancer. Cancers treated after transplant are associated with very high recurrence rates.[92] |
| Poorly-controlled HIV infection | Patients with poorly-controlled HIV (CD4+ T-cell count < 200 cells/mm3 and/or detectable HIV viral load) have a high incidence of HIV-related complications following LT, and 3/11 patients in one report died rapidly of HIV.[93] |
| Uncontrolled sepsis | Patients with active sepsis are generally too unstable to safely undergo LT. |
| Anatomic abnormality that precludes transplant | Anatomic features may prohibit the ability to perform LT (e.g. extensive mesenteric thrombosis). |
| Patient preference to decline transplant | Autonomy is a central principle of biomedical ethics, and fully informed patients may wish to decline LT in favor of hospice.[94] |
Abbreviations: LT, liver transplantation; mPAP, mean pulmonary arterial pressure; BMI, body mass index; HCC, hepatocellular carcinoma; HIV, human immunodeficiency virus